Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy

References

• Armutlu P, Ozdemir ME, Uney-Yuksektepe F, et al. (2008). Classification of drug molecules considering their IC50 values using mixed-integer linear programming based hyper-boxes method. BMC Bioinformatics 9:411
   PubMed Web of Science ®Google Scholar
• Deepa K, Singha S, Panda T. (2014). Doxorubicin nanoconjugates. J Nanosci Nanotechnol 14:892–904
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. (2008). Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3:133–49
   PubMed Web of Science ®Google Scholar
• Dong D, Gao W, Liu Y, et al. (2015). Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer. Cancer Lett 359:178–86
   PubMed Web of Science ®Google Scholar
• Esposito E, Ravani L, Drechsler M, et al. (2015). Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study. Mater Sci Eng C Mater Biol Appl 48:328–36
   PubMed Web of Science ®Google Scholar
• Fan X, Chen J, Shen Q. (2013). Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. Int J Pharm 458:296–304
   PubMed Web of Science ®Google Scholar
• Fong YK, Li CR, Wo SK, et al. (2012). In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein. J Ethnopharmacol 141:742–53
   PubMed Web of Science ®Google Scholar
• Greco F, Vicent MJ. (2009). Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev 61:1203–13
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang L, Lv P, et al. (2015). Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer. Oncol Lett 9:1065–72
   PubMed Web of Science ®Google Scholar
• Harush-Frenkel O, Rozentur E, Benita S, et al. (2008). Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9:435–43
   PubMed Web of Science ®Google Scholar
• How CW, Rasedee A, Manickam S, et al. (2013). Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity. Colloids Surf B Biointerfaces 112:393–9
   PubMed Web of Science ®Google Scholar
• Lee HZ, Leung HW, Lai MY, et al. (2005). Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 25:959–64
   PubMed Web of Science ®Google Scholar
• Lee T, Lim EK, Lee J, et al. (2013). Efficient CD44-targeted magnetic resonance imaging (MRI) of breast cancer cells using hyaluronic acid (HA)-modified MnFe2O4 nanocrystals. Nanoscale Res Lett 8:149
   PubMed Web of Science ®Google Scholar
• Liu L, Tang Y, Gao C, et al. (2014a). Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf B Biointerfaces 115:125–31
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang L, Zhao Y, et al. (2014b). Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Int J Pharm 476:169–77
   PubMed Web of Science ®Google Scholar
• Liu TY, Gong W, Tan ZJ, et al. (2015). Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX. PLoS One 10:e0114851
   Google Scholar
• Pardeike J, Hommoss A, Müller RH. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 366:170–84
   PubMed Web of Science ®Google Scholar
• Peng Y, Guo C, Yang Y, et al. (2015). Baicalein induces apoptosis of human cervical cancer HeLa cells in vitro. Mol Med Rep 11:2129–34
   PubMed Web of Science ®Google Scholar
• Platt VM, Szoka FC Jr. (2008). Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm 5:474–86
   PubMed Web of Science ®Google Scholar
• Rahman HS, Rasedee A, How CW, et al. (2013). Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomed 8:2769–81
   PubMed Web of Science ®Google Scholar
• Saraswathy M, Gong S. (2013). Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31:1397–407
   PubMed Web of Science ®Google Scholar
• Seo MJ, Choi HS, Jeon HJ, et al. (2014). Baicalein inhibits lipid accumulation by regulating early adipogenesis and m-TOR signaling. Food Chem Toxicol 67:57–64
   PubMed Web of Science ®Google Scholar
• Sun M, Nie S, Pan X, et al. (2014). Quercetin-nanostructured lipid carriers: characteristics and anti-breast cancer activities in vitro. Colloids Surf B Biointerfaces 113:15–24
   PubMed Web of Science ®Google Scholar
• Taratula O, Kuzmov A, Shah M, et al. (2013). Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release 171:349–57
   PubMed Web of Science ®Google Scholar
• Tichota DM, Silva AC, Sousa Lobo JM, et al. (2014). Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration. Int J Nanomed 9:3855–64
   PubMed Web of Science ®Google Scholar
• Trapani A, Mandracchia D, Di Franco C, et al. (2015). In vitro characterization of 6-Coumarin loaded solid lipid nanoparticles and their uptake by immunocompetent fish cells. Colloids Surf B Biointerfaces 127C:79–88
   Web of Science ®Google Scholar
• Tsai MJ, Wu PC, Huang YB, et al. (2012). Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 423:461–70
   PubMed Web of Science ®Google Scholar
• Wang N, Ren D, Deng S, et al. (2014). Differential effects of baicalein and its sulfated derivatives in inhibiting proliferation of human breast cancer MCF-7 cells. Chem Biol Interact 221:99–108
   PubMed Web of Science ®Google Scholar
• Yan X, Rui X, Zhang K. (2015). Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway. Oncol Rep 33:737–43
   PubMed Web of Science ®Google Scholar
• Yang X, Lyer AK, Singh A, et al. (2015). MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer. Sci Rep 5:8509
   PubMed Web of Science ®Google Scholar
• Yuan L, Liu C, Chen Y, et al. (2013). Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model. Int J Nanomed 8:4339–50
   PubMed Web of Science ®Google Scholar
• Zaro JL. (2015). Lipid-based drug carriers for prodrugs to enhance drug delivery. AAPS J 17:83–92
   PubMed Web of Science ®Google Scholar
• Zhao X, Chen Q, Liu W, et al. (2014). Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. Int J Nanomed 10:257–70
   PubMed Web of Science ®Google Scholar
• Zhang TC, Chen JN, Zhang Y, et al. (2011). Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur J Pharm Sci 43:174–9
   PubMed Web of Science ®Google Scholar
• Zhang H, Li J, Sun W, et al. (2014). Hyaluronic acid-modified magnetic iron oxide nanoparticles for MR imaging of surgically induced endometriosis model in rats. PLoS One 9:e94718
   Google Scholar